UNSPSC 51281623: Sisomicin

This classification denotes an aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X55XSL74YQ. European Medicines Agency schedules Sisomicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10538MIG. Sisomicin generally arises in the molecular formula C19H37N5O7. The term SISOMICIN is an International Non-Proprietary Name or INN. SISOMICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule sisomicin under HS 29419000 and SITC 54139. As of Q4 2014, SISOMICIN remains the US FDA Preferred Term for this commodity. Sisomicin bears US NLM identifiers UMLS ID C0037209 and NCI Concept Code C72569. SMILES: O(C1C(O)C(OC2OC(=CCC2N)CN)C(N)CC1N)C1OCC(O)(C(NC)C1O)C.

UNSPSC 51281623 Sisomicin, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The two opportunities tagged under this code involve pharmaceutical products — one an awarded piggyback contract for antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) through a consortium vehicle, and the other a competitive bid for Naloxone and drug deactivation systems — but neither opportunity directly solicits Sisomicin or aminoglycoside antibiotics. State and local governments do procure pharmaceutical inventory through cooperative purchasing agreements and direct IFB processes, often bundling multiple drug SKUs in a single contract and leveraging consortium frameworks such as MMCAP to achieve volume pricing and standardized terms across jurisdictions.

The issuing bodies active in this space include state health departments and county health authorities. The Illinois Department of Public Health awarded a $2,999,999.11 contract through MMCAP Infuse to Chartwell Rx LLC (posted August 28, 2026, response deadline September 11, 2026) for a 12-month initial term with two renewal options, while Seminole County, Florida solicited Naloxone and deactivation systems through a competitive IFB (posted June 30, 2026, due July 26, 2023) with quarterly deliveries and two-year initial term plus one-year renewal option. Geographic activity spans Florida and Illinois based on recent notices, with contract administration typically at state or county health department offices. The code's low posting volume and the mismatch between the code name and the actual products solicited suggest limited direct procurement of Sisomicin at the state and local level; vendors pursuing this commodity should monitor health department RFQs and piggyback-contract updates rather than expect stand-alone Sisomicin solicitations.